Suchen
Rxsight Inc
RXSTZur Watchlist hinzufügen
6.105USD
+0.085+1.41%
Handelsschluss 09-14 16:00（ET）
253.67MMarktkapitalisierung
VerlustKGV TTM
mehr Informationen über Rxsight Inc Unternehmen
RxSight, Inc. is a commercial-stage medical technology company dedicated to providing customized vision to patients following cataract surgery. The Company's proprietary RxSight Light Adjustable Lens system (RxSight system) is commercially available premium cataract technology that enables doctors to customize and optimize visual acuity for patients after surgery. The RxSight system consists of its RxSight Light Adjustable Lens (LAL), the RxSight Light Delivery Device (LDD), and accessories. Its LAL is an intraocular lens (IOL) made of photosensitive material that changes shape in response to specific patterns of ultraviolet (UV) light generated by its LDD. In contrast, with the RxSight system, the surgeon implants the LAL during a standard cataract procedure, determines refractive error with patient input several weeks following surgery and then uses the LDD to modify the LAL with the precise visual correction needed to achieve the patient's desired vision outcomes.
Rxsight Inc Profil
BörsenkürzelRXST
Name des UnternehmensRxsight Inc
IPO-datumJul 30, 2021
CEOKurtz (Ron M)
Anzahl der mitarbeiter498
WertpapierartOrdinary Share
GeschäftsjahresendeJul 30
Addresse100 Columbia Street
StadtALISO VIEJO
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited States of America
Postleitzahl92656
Telefon19495217822
Websitehttps://www.rxsight.com/
BörsenkürzelRXST
IPO-datumJul 30, 2021
CEOKurtz (Ron M)
Führungskräfte von Rxsight Inc
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Eric Weinberg
Mr. Eric Weinberg
Co-President, Chief Business Development Officer
Co-President, Chief Business Development Officer
501.25K
-0.41%
Mr. Eric Weinberg
Mr. Eric Weinberg
Co-President, Chief Business Development Officer
Co-President, Chief Business Development Officer
501.25K
-0.41%
Dr. William J. Link, Ph.D.
Dr. William J. Link, Ph.D.
Independent Director
Independent Director
96.14K
+38.52%
Dr. William J. Link, Ph.D.
Dr. William J. Link, Ph.D.
Independent Director
Independent Director
96.14K
+38.52%
Dr. Ilya Goldshleger, Ph.D.
Dr. Ilya Goldshleger, Ph.D.
Chief Operating Officer
Chief Operating Officer
82.88K
-2.46%
Dr. Ilya Goldshleger, Ph.D.
Dr. Ilya Goldshleger, Ph.D.
Chief Operating Officer
Chief Operating Officer
82.88K
-2.46%
Mr. Robert J. (Bob) Palmisano
Mr. Robert J. (Bob) Palmisano
Independent Director
Independent Director
78.08K
+47.44%
Mr. Robert J. (Bob) Palmisano
Mr. Robert J. (Bob) Palmisano
Independent Director
Independent Director
78.08K
+47.44%
Ms. Shweta Singh Maniar
Ms. Shweta Singh Maniar
Independent Director
Independent Director
55.17K
+67.13%
Ms. Shweta Singh Maniar
Ms. Shweta Singh Maniar
Independent Director
Independent Director
55.17K
+67.13%
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Eric Weinberg
Mr. Eric Weinberg
Co-President, Chief Business Development Officer
Co-President, Chief Business Development Officer
501.25K
-0.41%
Mr. Eric Weinberg
Mr. Eric Weinberg
Co-President, Chief Business Development Officer
Co-President, Chief Business Development Officer
501.25K
-0.41%
Dr. William J. Link, Ph.D.
Dr. William J. Link, Ph.D.
Independent Director
Independent Director
96.14K
+38.52%
Dr. William J. Link, Ph.D.
Dr. William J. Link, Ph.D.
Independent Director
Independent Director
96.14K
+38.52%
Dr. Ilya Goldshleger, Ph.D.
Dr. Ilya Goldshleger, Ph.D.
Chief Operating Officer
Chief Operating Officer
82.88K
-2.46%
Dr. Ilya Goldshleger, Ph.D.
Dr. Ilya Goldshleger, Ph.D.
Chief Operating Officer
Chief Operating Officer
82.88K
-2.46%
Häufig gestellte Fragen
Wer sind die fünf größten Anteilseigner von Rxsight Inc?
Die fünf größten Anteilseigner von Rxsight Inc sind: Mr. Eric Weinberg
Wie viele Institutionen halten Anteile an Rxsight Inc (RXST)?
Mit Stand vom 2026Q1 halten 467 Institutionen Anteile an Rxsight Inc, mit einem Gesamtmarktwert von etwa 38.60M, was 93.24% der Gesamtanteile entspricht. Im Vergleich zum 2025Q4 ist der institutionelle Aktienbesitz um -10991579.00 gestiegen.